OI
ONTO INNOVATION INC. (ONTO)·Q1 2024 Earnings Summary
Executive Summary
- Revenue of $228.8M and non-GAAP EPS of $1.18 landed at the high end of guidance, driven by AI-related HBM and logic packaging demand; GAAP gross margin was 52% .
- Specialty and advanced packaging revenue set another quarterly record, with Dragonfly G3 shipments up ~30% QoQ; management introduced a new Dragonfly subsurface defect sensor to enable 100% wafer inspection for ultrathin HBM wafers .
- Q2 2024 guidance: revenue $230–$240M, GAAP EPS $0.88–$1.00, non-GAAP EPS $1.14–$1.26; management also guided gross margin to 52–54% and OpEx to $62–$64M, implying sequential margin improvement .
- Catalysts: sustained AI packaging demand through Q2; new defect sensor and panel lithography (glass) shipments; watch for a potential modest “digestion” in AI packaging around Q3 before reacceleration into Q4 and a stronger 2025 setup .
What Went Well and What Went Wrong
What Went Well
- AI packaging demand maintained record levels: “Strong and anticipated demand for high-bandwidth memory and logic packaging for AI devices resulted in first quarter revenue at the very high end of our guidance range” . Dragonfly G3 shipments rose ~30% QoQ to support AI packaging .
- Cash generation and operating efficiency: operating cash flow of $57M (25% of revenue), converting ~100% of operating income into cash .
- Product innovation and adoption: new Dragonfly subsurface defect sensor for ultrathin HBM wafers; first JetStep lithography system shipment to support glass panel substrates, with management positioning panel-level packaging and glass as enabling next-gen chiplet architectures .
What Went Wrong
- Power semiconductor revenue softness: “After a record year in 2023, revenue from power device manufacturers declined in the first quarter,” though growth is expected to return in Q2 and through the second half .
- Advanced nodes remain at low levels: revenue “incrementally improved as expected, but remains at quite low levels”; management expects sequential growth but highlighted uncertainty around broader ramps until late 2024/2025 .
- Packaging “digestion” risk: management signaled a potential modest digestion in AI packaging in Q3 before renewed strength, adding near-term forecasting uncertainty around quarterly phasing .
Financial Results
Consolidated Financials (GAAP and non-GAAP)
Notes: Q1 2024 revenue growth +5% QoQ and +15% YoY; non-GAAP EPS +11% QoQ and +28% YoY per CFO commentary .
Segment/Market Breakdown
Discrepancy note: The press release cited $161M for specialty & advanced packaging; CFO clarified on the call the quarter was $158M .
Operational KPIs
Guidance Changes
Reference guidance context: Q1 2024 prior guidance was revenue $215–$230M; GAAP EPS $0.74–$0.94; non-GAAP EPS $1.00–$1.20 .
Earnings Call Themes & Trends
Management Commentary
- “Strong … demand for high-bandwidth memory and logic packaging for AI devices resulted in first quarter revenue at the very high end of our guidance range” — CEO Michael Plisinski .
- “Our Dragonfly platform has been enhanced with a new sensor to detect subsurface defects at production capable speeds … orders from several customers and shipments starting in the second quarter” — CEO .
- “We expect gross margins will improve to 52% to 54% … we anticipate our non-GAAP earnings for the second quarter to be between $1.14 per share to $1.26 per share” — CFO Mark Slicer .
- “We are on track to ship our first JetStep system to support lithography on glass panels … critical to realize high volume and high-performance chiplet architectures” — CEO .
- “Outlook for the year is improving … second half … incrementally higher providing nice momentum going into … a stronger year … in 2025” — CEO .
Q&A Highlights
- Advanced nodes breadth: NAND demand driven by enterprise SSDs for AI servers (200+ layer stacks); Atlas/Aspect established tool-of-record positions; logic adoption continuing for Atlas OCD and Iris planar films .
- Quarter-to-quarter phasing: management framed H2 growth as incremental (single digits, ~3–7% half-on-half), with potential Q3 digestion before reacceleration .
- Segment discrepancy clarified: CFO confirmed specialty & advanced packaging revenue was $158M vs $161M cited in the press release .
- Lead times and capacity: Dragonfly lead times ~3–6 months on build-to-forecast; sustained strength across the three HBM suppliers and AI logic packaging providers .
- Margin drivers: sequential GM improvement anticipated from supply chain initiatives and product mix; lithography margins improving from very low initial orders .
Estimates Context
- S&P Global Wall Street consensus estimates for ONTO were unavailable in this session due to SPGI request limits. As a result, numeric comparisons vs consensus cannot be provided and should be treated as unavailable for Q1 2024 and Q2 2024 guidance. The analysis above references company guidance and actuals from primary documents .
Key Takeaways for Investors
- AI packaging continues to be the primary growth engine; Dragonfly shipments and specialty/AP revenue remain robust into Q2, supporting high-end guidance outcomes .
- Watch Q3 for a modest digestion in AI packaging before potential strength in Q4; management still expects H2 to be modestly higher and sets a stronger 2025 narrative with advanced nodes and panel lithography scaling .
- Sequential gross margin improvement is a near-term pillar (52–54% guided in Q2) driven by supply chain actions and product mix; OpEx peaks seasonally in Q2 before tapering in H2 .
- Advanced nodes show green shoots: logic and NAND orders emerging with Atlas/Aspect/Iris, and steady GAAR preparation; expect sequential growth from a low base in 2024, more meaningful impact in 2025 .
- Power semis paused in Q1 but reaccelerate in Q2 and likely remain strong in H2; process control value proposition supports output and yield even amid capex moderation .
- Strategic optionality from panel lithography and glass substrates: initial shipments begin, positioning ONTO for enabling higher-density interconnects and future chiplet architectures .
- Cash generation remains healthy with disciplined working capital; $57M OCF (25% of revenue) and $741M cash/marketable securities provide flexibility for execution and investment .